RIG
43
6
PM
54
4
R
66
3
RSG
70
2
PX
63
3
HAL
50
2
VZ
44
2
VNO
59
3
PRGO
36
4
MAR
68
3
VMC
63
10
BA
56
3
AN
49
3
LYB
48
2
CI
66
7
UNM
74
2
DAL
85
6
VTR
52
3
HOG
39
5
WY
50
6
RIG
43
6
PM
54
4
R
66
3
RSG
70
2
PX
63
3
HAL
50
2
VZ
44
2
VNO
59
3
PRGO
36
4
MAR
68
3
VMC
63
10
BA
56
3
AN
49
3
LYB
48
2
CI
66
7
UNM
74
2
DAL
85
6
VTR
52
3
HOG
39
5
WY
50
6
Financhill
Back

Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF Vs. Kymera Therapeutics Industry Stock Comparison

Buy
58

SKRE
Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF

Last Price:
15.10
Seasonality Move:
--
Buy
71

KYMR
Kymera Therapeutics

Last Price:
46.27
Seasonality Move:
65.72%
Buy
58
Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF (SKRE) is a Buy

Is Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF a Buy, Sell or Hold?

  • The current Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF [SKRE] share price is $15.38. The Score for SKRE is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • SKRE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

  • The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
  • KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

SKRE Stock Price Chart

What is Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF's stock price today?

  • The Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF share price today is $15.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SKRE is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

  • The Kymera Therapeutics share price today is $49.02
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.

SKRE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 30.93 Sell
Chaikin Money Flow: 656 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.57 - 18.35) Sell
Bollinger Bands (100): (16.84 - 24.66) Sell

KYMR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.28 Sell
Relative Strength Index (14 RSI): 59.12 Buy
Chaikin Money Flow: 317205 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.81 - 49.49) Buy
Bollinger Bands (100): (34.86 - 47.92) Buy

SKRE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.84 Sell
20-day SMA: 17.36 Sell
50-day SMA: 18.13 Sell
200-day SMA: 0 Buy
8-day EMA: 16.54 Sell
20-day EMA: 17.23 Sell
50-day EMA: 18.26 Sell
200-day EMA: 2.26 Buy

KYMR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.58 Buy
20-day SMA: 46.67 Buy
50-day SMA: 46.11 Buy
200-day SMA: 38.62 Buy
8-day EMA: 45.67 Buy
20-day EMA: 45.85 Buy
50-day EMA: 45.2 Buy
200-day EMA: 38.5 Buy

Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF Earnings Growth & SKRE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

Tuttle Cptl Dl 2X Invrs Rgnl Banks ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):